Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) shares jumped 42.8% to $5.60 after the FDA lifted clinical hold on the company’s FTX-6058 for sickle cell disease.
acnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acnnewswire.com Daily Mail and Mail on Sunday newspapers.
MIL-OSI: Ascendiant Capital Markets: Society Pass Inc (Nasdaq: SOPA) 2Q 2023 Saw Strong Revenue Growth of 338% Year on Year; Major Acquisition and Expected Cash Probability in 2H 2023 to Drive Share Price Higher foreignaffairs.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from foreignaffairs.co.nz Daily Mail and Mail on Sunday newspapers.
Ascendiant Capital Markets: Society Pass Inc (Nasdaq: SOPA) 2Q 2023 Saw Strong Revenue Growth of 338% Year on Year; Major Acquisition and Expected Cash Probability in 2H 2023 to Drive Share Price Higher jcnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jcnnewswire.com Daily Mail and Mail on Sunday newspapers.